Jahr: 2024

joimax® Unveils New Website, Celebrates 20 Years of TESSYS® at Global Spine Congress (GSC) in Bangkok

Veröffentlicht am von Thuy Ngo

KARLSRUHE, Germany–(BUSINESS WIRE)–German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, announces the launch of its new website alongside a significant presence at the Global Spine Congress (GSC) in Bangkok, May 15 – 18. This dual celebration marks a pivotal moment for the company as it showcases its latest product innovations and commemorates two decades of excellence with TESSYS®, a pioneering technique that has revolutionized endoscopic spine surgery.

“These advancements are game-changers in endoscopic spine surgery, especially the transforaminal approach and will undoubtedly revolutionize how to tackle complex spinal procedures.”

The new website provides a seamless digital experience for customers and partners, worldwide. With enhanced features and user-friendly navigation, www.joimax.com serves as a comprehensive hub of information on joimax®’s cutting-edge endoscopic spine surgery solutions.

At GSC, joimax® is not only celebrating 20 years of TESSYS®, but also exhibiting an array of product innovations, such as TESSYS® Trans SAP with the newest Double Drill, ilESSYS® Biportal, the RoboFIX® robotorized Arm, and the Camsource® Duo, which further enhances surgical precision and visualization, ultimately improving patient outcomes.

“We are immensely proud of the impact TESSYS® has had on the field of endoscopic spine surgery,” stated joimax® CEO and President Wolfgang Ries. “joimax® has pioneered the transforaminal approach, building upon and enhancing Parviz Kambin’s original concept, influencing our path to endoscopic fusion. Our commitment to excellence remains unwavering as we continue to push the boundaries of what’s possible in minimally invasive spine surgery.”

Feedback from surgeons has been overwhelmingly positive, with many expressing enthusiasm for joimax®’s “fireworks of innovations”. Dr. Frank Hassel, Chief Physician Spinal Surgery and Medical Director, Loretto Krankenhaus Freiburg, Germany; Prof. Junseok Bae, President, Wooridul Spine Hospital, Seoul, South Korea; and Prof. Christoph P. Hoftstetter, Professor of Neurological Surgery, Cape Cod Healthcare, Hyannis, USA issued this group statement: “These advancements are game-changers in endoscopic spine surgery, especially the transforaminal approach and will undoubtedly revolutionize how to tackle complex spinal procedures.”

Also at GSC, joimax® is hosting expert talks, and leading basic and advanced workshops. From groundbreaking technologies to intuitive surgical tools, joimax® continues to lead the way in providing surgeons with the necessary resources to address a wide-range of spinal issues. To learn more about joimax®’s innovations, visit www.joimax.com or stop by the joimax® GSC booths 2 and 3.

joimax® obtains registration for all products in the Indian market

Veröffentlicht am von christine.stump@joimax.com

KARLSRUHE, Germany–(BUSINESS WIRE)–German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce the full registration of all its products for India, one of the fastest growing endoscopic spine surgery markets worldwide.

The Indian registration includes all joimax® Class II and III, as well as Class I instruments, which were approved in 2023. Now, the Indian health community has access to all the latest spinal endoscopic technologies invented, developed and manufactured by joimax®.

“India is the biggest country in the world; it’s ready for emerging technology businesses like endoscopic spinal surgery,” states Santhosh Mechery, Director Spectramed Healthcare (P) Ltd. “We can’t wait to roll-out the complete joimax® portfolio in our country and enable so many patients to profit from this innovative, minimally invasive endoscopic spine surgery.”

“Earlier this year, joimax® received its CE MDR approvals, granted by TÜV-South — an important step for marketing our existing products under the new European regulation, which opened a backlog of products to India,” states joimax® Founder and CEO Wolfgang Ries. “We’re already active in more than 60 countries! These partners are eager to launch the newest joimax® treatment technologies.”

In Fall 2022, joimax®, in cooperation with Spectramed Healthcare, launched its education and training program, Endoscopic Spine Academy (ESPINEA®), in India, which has since been rolled out worldwide. ESPINEA® was founded in 2019, accredited by the Royal College of Surgeons of Edinburgh in 2020, and this year, is celebrating its 5th anniversary. The program allows for the highest quality training of joimax® products in any market, serving as a hands-on learning facility for endoscopic spinal surgery.

Expansion of training offerings with technology from Corin and joimax®at the ORSI ACADEMY

Veröffentlicht am von Antonio Berlen

Melle, Belgium –(ORSI ACADEMY)- Orsi Academy, the unique training & expertise centre for robotic and minimally invasive surgery in Melle, is once more enhancing its training facilities. With the support of the European Regional Development Fund, made available by VLAIO, it invested in revolutionizing robotic technology from Corin and latest navigation systems from joimax®. This equipment allows Orsi Academy to further expand its offer in clinical disciplines such as navigated spinal surgery, neurosurgery and orthopaedic surgery, particularly in knee and hip replacements. With the investment, Orsi Academy continues to contribute to improve and increase the quality and safety of our modern healthcare system.

“With the investment, Orsi continues to improve and increase the quality and safety of our modern healthcare system.”

Corin’s revolutional orthopaedic OMNIBotics System is designed to enhance precision to the balancing and implantation of knee replacements. This partnership will undoubtedly elevate the standards in training in orthopaedic surgical procedures.

Simultaneously, through a partnership with joimax®, Orsi Academy aims to pioneer advancements in spinal surgery. joimax®’s Intracs System is a smart navigation system based on electromagnetic tracking ensuring an easy and safe access to any spinal target.

The grant from the European Regional Development Fund plays a crucial role in financing the acquisition of these technologies, marking a significant milestone for Orsi Academy. This partnership not only integrates two remarkable platforms into its robotic family but also expands the training offerings, providing healthcare professionals with hands-on experience in the latest minimally invasive techniques.

Giovanni Tegami, Managing Director Corin Belgium

“Corin is honored to collaborate with Orsi Academy in advancing orthopaedic surgery training. Our robotic technology aims to enhance outcomes by restoring proper soft tissue balance and leg alignment, crucial factors in knee replacement success. Through this partnership, we’re eager to contribute to elevating standards in orthopaedic surgical procedures.”

Wolfgang Ries, Founder and CEO of the joimax® Group

“Being able to offer the Intracs® EM navigation system at any course held at the Orsi Academy for training and research needs is huge. It allows participants to directly experience the ease of use in endoscopic spine surgery and learn the difference of non-navigated and fully navigated procedures significantly driving the accelerating adoption rate of endoscopy in spine, which sees very fast growing high level literature on new applications, but also on major patient and surgeon benefits!”

Prof. Dr. Thomas Luyckx, Medical Leadership Orthopaedics Orsi Academy

“We are excited about the possibilities and advancements this collaboration will bring. This grant and collaboration reaffirms our dedication to pushing the boundaries of orthopaedic medical education.”

joimax® Expands Distribution in Italy – Announces New Partnership with Uber Ros S.p.A

Veröffentlicht am von Antonio Berlen

KARLSRUHE, Germany–(BUSINESS WIRE)–German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, and distributor Uber Ros S.p.A are excited to announce their new partnership for the Italian market, effective immediately.

Under this strategic alliance, Uber Ros will be a full sales and service provider of joimax® products to surgeons and medical practitioners throughout Italy. The partnership allows both companies to expand the renowned joimax® brand via first-rate networks and distribution channels to the Italian health community, ensuring that patients have access to the latest spinal endoscopic technologies.

“We’re looking forward to working with Uber Ros, a strong and well-established partner in Italy,” says joimax® Founder and CEO Wolfgang Ries.

“Together, we will continue to provide best-in-class service and grow our presence in the Italian spine community while creating a solid business growth strategy,” states Uber Ros President and COO Giorgio Rosati.

In addition, the acclaimed joimax® training and education program for spine physicians, managed under ESPINEA®, the Endoscopic Spine Academy powered by joimax®, will be introduced in Italy. “Uber Ros and joimax® will align all education activities and set-up special workshop programs that offer certified courses to Italian physicians,” says ESPINEA® Chairman Wolfgang Ries.

About Uber Ros S.p.A

Uber Ros S.p.A was founded in Rome in 1986 by Dr. Umberto Rosati and his son Giorgio. It is a Medical Devices Distribution Company active in all Italian territories. Uber Ros promotes and sells high-tech medical devices, mainly specialized in Orthopedics, Trauma Surgery, Neurosurgery, Spine, Maxillo-Facial, Head and Neck surgery (ENT-OTO), Wound Care and Vascular surgery. Uber Ros has a sales organization spread throughout Italy, providing customer service 24 hours on any day of the year. The Company collaborates with the world leading Research Centers, and is involved in the most advanced studies on bioengineering, promoting and supporting scientific research in high-tech emerging fields.